On one hand, knocking-down OCT4 in embryonal carcinoma cells increased the levels of AKT1 mRNA, pAKT-T308 and pAKT-S47317, and reversely, inhibiting the PI3K/AKT pathway increased OCT4 expression in glioblastoma CSCs32. This evidence concerns the gene AKT1 and embryonal carcinoma.